Precigen Inc $ 9.28 1.145 (14.07%)
Volume:
5,415,630
Avg Vol (1m):
1,743,667
Market Cap $:
1.74 Bil
Enterprise Value $:
1.85 Bil
P/E (TTM):
0.00
P/B:
26.21
Current and historical daily P/E ratio for Precigen Inc () from 2013 to Jan 27 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Precigen stock (PGEN) PE ratio as of Jan 27 2021 is 0.
More Details
Precigen PE Ratio (TTM) Chart
EMBED
Precigen PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1258
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Precigen PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2021-01-27 | 0.0 | 2020-11-25 | 0.0 |
| 2021-01-26 | 0.0 | 2020-11-24 | 0.0 |
| 2021-01-25 | 0.0 | 2020-11-23 | 0.0 |
| 2021-01-22 | 0.0 | 2020-11-20 | 0.0 |
| 2021-01-21 | 0.0 | 2020-11-19 | 0.0 |
| 2021-01-20 | 0.0 | 2020-11-18 | 0.0 |
| 2021-01-19 | 0.0 | 2020-11-17 | 0.0 |
| 2021-01-18 | 0.0 | 2020-11-16 | 0.0 |
| 2021-01-15 | 0.0 | 2020-11-13 | 0.0 |
| 2021-01-14 | 0.0 | 2020-11-12 | 0.0 |
| 2021-01-13 | 0.0 | 2020-11-11 | 0.0 |
| 2021-01-12 | 0.0 | 2020-11-10 | 0.0 |
| 2021-01-11 | 0.0 | 2020-11-09 | 0.0 |
| 2021-01-08 | 0.0 | 2020-11-06 | 0.0 |
| 2021-01-07 | 0.0 | 2020-11-05 | 0.0 |
| 2021-01-06 | 0.0 | 2020-11-04 | 0.0 |
| 2021-01-05 | 0.0 | 2020-11-03 | 0.0 |
| 2021-01-04 | 0.0 | 2020-11-02 | 0.0 |
| 2021-01-01 | 0.0 | 2020-10-30 | 0.0 |
| 2020-12-31 | 0.0 | 2020-10-29 | 0.0 |
| 2020-12-30 | 0.0 | 2020-10-28 | 0.0 |
| 2020-12-29 | 0.0 | 2020-10-27 | 0.0 |
| 2020-12-28 | 0.0 | 2020-10-26 | 0.0 |
| 2020-12-25 | 0.0 | 2020-10-23 | 0.0 |
| 2020-12-24 | 0.0 | 2020-10-22 | 0.0 |
| 2020-12-23 | 0.0 | 2020-10-21 | 0.0 |
| 2020-12-22 | 0.0 | 2020-10-20 | 0.0 |
| 2020-12-21 | 0.0 | 2020-10-19 | 0.0 |
| 2020-12-18 | 0.0 | 2020-10-16 | 0.0 |
| 2020-12-17 | 0.0 | 2020-10-15 | 0.0 |
| 2020-12-16 | 0.0 | 2020-10-14 | 0.0 |
| 2020-12-15 | 0.0 | 2020-10-13 | 0.0 |
| 2020-12-14 | 0.0 | 2020-10-12 | 0.0 |
| 2020-12-11 | 0.0 | 2020-10-09 | 0.0 |
| 2020-12-10 | 0.0 | 2020-10-08 | 0.0 |
| 2020-12-09 | 0.0 | 2020-10-07 | 0.0 |
| 2020-12-08 | 0.0 | 2020-10-06 | 0.0 |
| 2020-12-07 | 0.0 | 2020-10-05 | 0.0 |
| 2020-12-04 | 0.0 | 2020-10-02 | 0.0 |
| 2020-12-03 | 0.0 | 2020-10-01 | 0.0 |
| 2020-12-02 | 0.0 | 2020-09-30 | 0.0 |
| 2020-12-01 | 0.0 | 2020-09-29 | 0.0 |
| 2020-11-30 | 0.0 | 2020-09-28 | 0.0 |
| 2020-11-27 | 0.0 | 2020-09-25 | 0.0 |
| 2020-11-26 | 0.0 | 2020-09-24 | 0.0 |
Precigen PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Compare
NAS:MRUS
NAS:RAPT
NAS:MCRB
NAS:FULC
NAS:STSA
NAS:BSTC
NAS:CPRX
NAS:PTGX
NAS:PBYI
NAS:AGEN
OCSE:NOVO B
ASX:CSL
NAS:VRTX
NAS:REGN
XKRX:207940
NAS:SGEN
NAS:MRNA
NAS:ALXN
XKRX:068270
NAS:INCY
Address
20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.